GREGOIRE DANIEL N 4

4 · MAGELLAN HEALTH INC · Filed Dec 4, 2017

Form 4

Period: 2017-12-01

General Counsel and Secretary

Transactions

Sale
Ordinary Common Stock, $0.01 par value
2017-12-01$89.08/sh−8,275$737,137→ 13,457 total
Exercise of In-Money
Ordinary Common Stock, $0.01 par value
2017-12-01$64.87/sh+5,042$327,075→ 21,732 total
Exercise of In-Money
Stock Options (right to buy)
2017-12-01−5,042→ 10,083 total
Exercise: $64.87Exp: 2026-03-03→ Common Stock (5,042 underlying)
Exercise of In-Money
Stock Options (right to buy)
2017-12-01−3,233→ 12,538 total
Exercise: $63.95Exp: 2025-03-04→ Common Stock (3,233 underlying)
Exercise of In-Money
Ordinary Common Stock, $0.01 par value
2017-12-01$63.95/sh+3,233$206,750→ 16,690 total

Footnotes (5)

[F1]This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
[F2]The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $88.50 to $90.30, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
[F3]The remainder of 12,538 options shall vest on March 4, 2018.
[F4]Not applicable.
[F5]The remainder of 10,083 options shall vest in equal increments on March 3 of 2018 and 2019.

Documents

1 file